Showing results (991-1000 of 2,443) with videos related to

Sort By:
Pageof 245
BMC Public Health|September 3, 2014
Development and testing of a past year measure of sedentary behavior: the SIT-QBrigid M Lynch, Christine M Friedenreich, Farah Khandwala, et al.
Ophthalmology and Therapy|June 24, 2021
Timing of Quiescence and Uveitis Recurrences After Cataract Surgery in Patients with a History of UveitisAustin Rohl, Jennifer L Patnaik, D Claire Miller, et al.
Heredity|November 24, 2018
Ejaculate sperm number compensation in stalk-eyed flies carrying a selfish meiotic drive elementLara C Meade, Deidre Dinneen, Ridhima Kad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 19, 2008
Health behaviors of Australian colorectal cancer survivors, compared with noncancer population controlsAnna L Hawkes, Brigid M Lynch, Danny R Youlden, et al.
Dalton Transactions (Cambridge, England : 2003)|April 14, 2022
Diosgenin derivatives developed from Pd(II) catalysed dehydrogenative coupling exert an effect on breast cancer cells by abrogating their growth and facilitating apoptosis <i>via</i> regulating the AKT1 pathwayS Dharani, G Kalaiarasi, M Ravi, et al.
The Journal of Organic Chemistry|May 11, 2002
Synthesis of azapolycyclic systems via the intramolecular [4 + 2] cycloaddition chemistry of 2-(alkylthio)-5-amidofuransAlbert Padwa, John D Ginn, Scott K Bur, et al.
Prostaglandins & Other Lipid Mediators|July 5, 2011
The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancyCaoimhe M Lynch, Ruth O'Kelly, Bernard Stuart, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1995
Two [7.3.1]azabicyclo-z-3-ene-1,5-diyne analogues of dynemicin AV M Lynch, R A Fairhurst, T N Iliadis, et al.
Carcinogenesis|June 1, 1991
The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetryA M Lynch, S Murray, A R Boobis, et al.
Human Gene Therapy|October 10, 1997
GaLV pseudotyped vectors and cationic lipids transduce human CD34+ cellsJ Dybing, C M Lynch, P Hara, et al.
Pageof 245